Lv11
48 积分 2023-04-06 加入
Engaging results with glofitamab in DLBCL
15天前
已完结
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
18天前
已完结
Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study
19天前
已完结
[Chinese expert consensus on the management of long-term complications after hematopoietic stem cell transplantation (2023)]
4个月前
已完结
[Chinese expert consensus on prevention of hepatitis B virus reactivation after allogeneic hematopoietic stem cell transplantation (2023)]
4个月前
已完结
Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant
6个月前
已完结
Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML
7个月前
已完结
Relative prognostic value of flow cytometric measurable residual disease before allogeneic hematopoietic cell transplantation for adults with MDS/AML or AML
7个月前
已完结
Acute myeloid leukaemia
8个月前
已完结
What Influences the Decision to Proceed to Transplant for Patients With AML in First Remission?
8个月前
已完结
皖公网安备34019202002308
